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INTRODUCTION: Laparoscopic cholecystectomy is the gold standard for the treatment of gallstone disease; however, adverse 
hemodynamic changes induced by increased intraabdominal pressure due to pneumoperitoneum are known to occur. Herein, we 
investigated the effects of pneumoperitoneum on oxidative stress markers, including paraoxonase, arylesterase, total oxidant status, 
and total antioxidant status, during laparoscopic cholecystectomy.
PATIENTS AND METHODS: Patients that underwent a laparoscopic cholecystectomy were classified as Group I, whereas patients 
that underwent surgical procedures for an abdominal wall hernia under general anesthesia were classified as Group II. Blood samples 
were obtained during the preoperative period, the perioperative period, and 24 hours after surgery (postoperative day 1). Leukocyte 
counts, neutrophil rates, paraoxonase activities, arylesterase activities, and total oxidant and antioxidant status levels were measured. 
RESULTS: The differences in leukocyte counts and neutrophil rates were not significant between the two groups. In Group I, 
no significant differences in the total oxidant and antioxidant status levels were identified; however, paraoxonase and arylesterase 
levels were lower on postoperative day 1. No significant changes were observed in the total oxidant status, total antioxidant status, 
and paraoxonase or arylesterase activities in Group II. The perioperative total antioxidant status and arylesterase level were higher 
in Group I in comparison to Group II.
CONCLUSION: Paraoxonase and arylesterase levels are useful markers in the evaluation of oxidative stress caused by intraab-
dominal pressure due to pneumoperitoneum. 
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INTRODUCTION
Laparoscopic cholecystectomy (LC), a minimally 
invasive procedure in which the gallbladder is removed, is 
a common operation and has gained worldwide acceptance 
as the gold standard surgical method to treat gallstone 
disease.1 Adverse hemodynamic changes associated 
with LC, such as reduced venous return and increased 
systemic vascular resistance, have primarily been linked 
to the increase in intraabdominal pressure (IAP) caused by 
pneumoperitoneum.2-7 Reduced abdominal visceral perfusion 
and portal venous flow have also been shown to occur in 
patients who underwent LC.8-11 This reduction in abdominal 
visceral perfusion could be an important cause of oxidative 
stress during laparoscopic surgical procedures. 12-15 
Paraoxonase (PON1) is an ester hydrolase that has both 
arylesterase and paraoxonase activities. Recently, roles 
for PON1 in a number of processes have been studied, 
including lipid and lipoprotein metabolism, as well as 
for their antiatherogenic and antioxidant properties.16-20 
Oxidative stress, which is the result of an increased number 
of lipid and protein oxidation products and decreased 
number of antioxidant enzymes and vitamins, has been 286
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reported to affect the expression and activities of PON1.16, 
20 Furthermore, oxidative stress has been shown to decrease 
PON1 activity and down-regulate the serum expression of 
PON1.16, 21-24
In the present clinical study, we aimed to investigate the 
effects of pneumoperitoneum on oxidative stress markers 
during LC, including paraoxonase activity, total oxidant 
status (TOS) and total antioxidant status (TAS).
MATERIALS AND METHODS
This study was performed in Konya Numune State 
Hospital. Group I patients underwent an LC procedure, 
whereas Group II patients underwent surgical procedures 
to treat abdominal wall hernias under general anesthesia. 
The presence of any of the following conditions was 
used as an exclusion criterion in this study: diabetes 
mellitus, neoplastic disease, inflammatory disease (such as 
infections and autoimmune disorders), hypercholesterolemia, 
hypertriglyceridemia, use of an antihypertensive medication, 
lipid-lowering drug use, antioxidant substance use, 
known secondary hypertension, chronic renal failure, 
cerebrovascular disease, ischemic heart disease, congestive 
heart failure, gastrointestinal disease or liver disease. 
The study protocol was approved by the Ethics 
Committee of the Meram Faculty of Medicine, Selcuk 
University, and was conducted according to the Declaration 
of Helsinki, Good Clinical Practice Guidelines. The 
participants were informed about the nature of the study and 
informed consents were obtained.
Blood samples were obtained preoperative, perioperative, 
and 24 hours after surgery (postoperative day 1). Serum 
specimens were centrifuged for 15 min at 3000 rpm, 
transferred to Eppendorf tubes, and stored at −80°C. The 
specimens were used to measure paraoxonase activity, TOS 
and TAS. 
Measurement of paraoxonase and arylesterase activities
Paraoxonase and arylesterase activities were measured 
by using paraoxon and phenylacetate as the substrates, 
respectively. The basal activity of paraoxonase was 
measured. The rate of paraoxon hydrolysis (diethyl-p-
nitrophenylphosphate) was measured by monitoring an 
increase in absorbance at 412 nm at 37°C on an autoanalyser 
(Beckman Coulter, Fullerton, CA, U.S.A.). The amount 
of generated p-nitrophenpl was calculated from the molar 
absorptivity coefficient at a pH of 8.5, which was 18290 
M-1cm-1.  20 Paraoxonase activity is expressed as U/L of 
serum. Phenylacetate was used as the substrate to measure 
arylesterase activity. One unit of arylesterase activity was 
defined as 1 μmol of phenol generated per min and is 
expressed as U/L of serum.25 
Measurement of the total antioxidant status
The TAS levels of the sera were determined using an 
automated measurement method based on bleaching of the 
characteristic color of a more s 2,2’-azino-bis [3-ethylbenz-
thiazoline-6-sulfonic acid (ABTS)] radical cation caused 
by antioxidants.26 The results are expressed in mmol Trolox 
equivalents/L.
Measurement of total oxidant status
The TOS levels of the sera were determined using a 
novel automated measurement method.27 Oxidants present in 
the sample oxidize the ferrous ion-o-dianisidine complexes 
into ferric ions. The oxidation reaction is enhanced by 
glycerol molecules that are abundantly present in the 
reaction medium. The ferric ions form a colored complex 
with xylenol orange in an acidic medium. Therefore, the 
color intensity, measured spectrophotometrically, is related 
to the total number of oxidant molecules present in the 
sample. The assay is calibrated with hydrogen peroxide and 
the results are expressed in terms of micromolar hydrogen 
peroxide equivalent per liter (μmol H2O2 equiv./L). 
Statistical analysis 
Statistical analysis was performed using SPSS software 
for Windows, release 13.0. Results are expressed as the mean 
± standard deviation (SD). Statistical analysis was performed 
using the Mann-Whitney U test and Paired t-test. Statistical 
significance was assumed at a level of P < 0.05.
RESULTS
The study presented here contained 20 patients who 
underwent an LC (Group I) and 10 patients who underwent 
a surgical procedure to treat an abdominal wall hernia under 
general anesthesia (Group II). In Group I, the median patient 
age was 49.5 years of age (range, 26-77 years), and 16 of 
the patients were female and 4 were male. In Group II, the 
median age was 44.5 years of age (range, 17-52 years), 
and five of the patients were female and five were male. In 
Group II, the diagnoses of the patients were either a groin or 
an umbilical hernia. Mean operation times for Groups I and 
II were 33.63±11.03 and 46.2±21.1 min, respectively. The 
difference in the respective mean operation times of the two 
groups was not statistically significant (p=0.22).287
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Leukocyte counts and neutrophil rates
The leukocyte counts and neutrophil rates in Groups I 
and II are shown in Table 1. 
In Group I, leukocyte counts in the perioperative period 
and on postoperative day 1 were higher than those during the 
preoperative period for both groups (p=0.013 and p=0.016, 
respectively). In Group II, the differences in leukocyte 
counts during the preoperative period, perioperative period, 
and on postoperative day 1 were not significant. 
The neutrophil rates on postoperative day 1 were higher 
than those during the preoperative period for both Groups I 
and II (p=0.001 and p= 0.009, respectively). 
Oxidative stress markers
Mean and SD values of PON1 and arylesterase activities, 
as well as TAS and TOS levels are presented in Table 2. 
No significant differences in TOS and TAS levels in 
Group I were observed. For Group I, the paraoxonase level 
on postoperative day 1 was significantly lower than the 
paraoxonase level during the preoperative period (p=0.035). 
Furthermore, the arylesterase activity in Group I during 
the preoperative period was higher than that during the 
perioperative period and on postoperative day 1. In addition, 
no significant changes in TOS, TAS, PON1, and arylesterase 
activities were noticed in Group II. Comparing Group I 
to Group II, the perioperative TAS level in Group I was 
significantly higher than the TAS level in Group II (p=0.04). 
In addition, the perioperative arylesterase level of Group I 
was higher (p=0.028) than that of Group II. 
DISCUSSION
LC, a minimally invasive, and effective safe technique, 
has become the gold standard for the surgical management 
Table 1 - Leukocyte counts and neutrophil rates of Groups I and II
GROUP I GROUP II P
Leukocyte counts (per mm3)
          Preoperative
          Perioperative
          Postoperative day 1
Neutrophil rates (%)
          Preoperative
          Perioperative
          Postoperative day 1
7772.72±2028.27
9027.27±2470.04
9022.72±2177.54
59.94±10.37
64.8±12.45
70.8±7.68
7790±1733.62
10140±3641.48
9700±2167.94
54.97±19.39
68.39±13.29
72.63±7.23
NS
NS
NS
NS
NS
NS
Abbreviations used: NS, not significant.
Table 2 - Activities of PON1 and arylesterase, as well as TAS and TOS levels, in Groups I and II
Preoperative Perioperative Postoperative day 1 p
GROUP I
Total Oxidant Status 
(μmol H2O2 equiv./L)
20.06±8.25 22.16±12.87 21.69±16.1 NS
Total Antioxidant
(mmol Trolox equivalents/L)
6.06±1.44 5.85±0.92 5.94±1.27 NS
Paraoxonase
(U/L)
224.55±133.44 209.15±107.89 190.35±97.60 †
Arylesterase
(U/L)
157.50±9.17 155.06±6.36 154.86±6.77 ‡
GROUP II
Total Oxidant Status
(μmol H2O2 equiv./L)
18.3±8.16 20.07±13.2 27.55±22.56 NS
Total Antioxidant
(mmol Trolox equivalents/L)
5.19±0.85 5.13±0.92 6.18±1.56 NS
Paraoxonase
(U/L)
184.84±130.45 171.77±76.14 178.74±109.39 NS
Arylesterase
(U/L)
150.72±3.99 150.06±3.36 150.56±3.24 NS
† indicates a significant difference in paroxonase activity in Group I during the preoperative period vs. postoperative day 1 (p=0.035).
‡ indicates a significant difference in arylesterase activity in Group I during the preoperative period vs. perioperative period (p=0.024) and during the 
preoperative period vs. postoperative day 1(p=0.046).288
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of cholelithiasis.1 Nevertheless, laparoscopy has its 
disadvantages, which are mostly due to an increase in 
IAP due to pneumoperitoneum. The increase in IAP due 
to pneumoperitoneum adversely affects the patient’s 
homeostasis. IAP causes significant changes in the 
cardiovascular and respiratory systems. IAP decreases 
perfusion in abdominal organs, decreases blood flow in 
the inferior vena cava and increases the risk of thrombotic 
disease.2-11 
The evaluation of oxidative stress can indirectly reflect 
the changes in microcirculation in the splanchnic area 
during insufflation in LC. Different oxidative stress markers 
have been investigated, including nitric oxide; levels of 
tissue and blood malondialdehyde and total antioxidant; 
and levels of thiobarbituric acid reactive substances to 
assess lipid peroxidation, protein carbonyl content, and 
protein sulfhydryl. In addition to these methods, lipid 
peroxidation has been used to reflect oxidative stress and 
total glutathione has been used to reflect actions against 
oxidative stress.12-15,28,29 
PON1, a high-density lipoprotein (HDL)-associated 
enzyme, has many enzymatic activities, including those 
associated with paraoxonase, arylesterase, dyazoxonase and 
Ca2+-dependent serum esterase.30,31 Decreased PON1 activity 
was observed in patients with different diseases, including 
coronary artery disease, hypercholesterolemia, type 2 
diabetes or iron-deficiency anemia.32-34 Decreased serum 
PON1 activities in different types of cancers (including lung, 
pancreatic, gastric, esophageal and prostate) have also been 
demonstrated.35-39 
To the best of our knowledge, paraoxonase and 
arylesterase, as known antioxidants, have not been 
evaluated in patients who underwent LC. The purpose of 
the present study was to evaluate the associations between 
pneumoperitoneum in LC with PON1 activity, arylesterase 
activity, TAS and TOS. 
Thiobarbituric acid-reactive substances are markers of 
free radical production. In a study by Glantzounis et al., 
plasma TAS levels were measured preoperatively, 5 minutes 
after deflation of the pneumoperitoneum or at the end of 
the operation and 24 h postoperatively.12 A significant 
elevation in the concentration of thiobarbituric acid-
reactive substances was observed in the early postoperative 
measurements  in  comparison  to  the  preoperative 
measurements conducted in the LC group in the present 
study. TAS and uric acid levels were significantly decreased 
on postoperative day 1 in comparison to preoperative 
levels; however, no alterations to the concentrations of 
thiobarbituric acid-reactive substances were observed in 
the postoperative period in patients who underwent an open 
cholecystectomy. 
In a study by Zulfikaroglu et al.,14 the effect of carbon 
dioxide insufflation on tissue and blood malondialdehyde, 
TAS, arterial blood gases, blood nitric oxide and end-
tidal carbon dioxide volume were examined. The total 
operation times for LC patients and open cholecystectomy 
patients were 46 and 53 minutes, respectively. Blood 
malondialdehyde levels were higher after 30 minutes in 
comparison to their levels on postoperative day 1 in both 
groups examined in the present study. In contrast, TAS levels 
did not change significantly. Therefore, we conclude that the 
antioxidant defense system was less stimulated due to less 
oxidative stress. 
Polat et al.15 investigated the effects of different IAPs 
on lipid peroxidation and protein oxidation status during 
LC. Thiobarbituric acid-reactive substance levels were used 
to assess lipid peroxidation and protein carbonyl contents. 
Protein sulfhydryl groups were also measured to assess 
protein oxidation status. In a study by Polat et al., the authors 
concluded that carbon dioxide insufflation could lead to an 
increased oxidative stress response during LC; however, no 
difference was found between the two examined groups.
Bukan  et  al.  observed  increasing  levels  of 
malondialdehyde, as well as nitrite and nitrate levels during 
both open cholecystectomy and LC.28 The oxidative stress 
increased significantly in both groups; however, LC caused 
significantly less oxidative stress during surgery. The 
oxidative stress level returned to preoperative levels more 
quickly after LC. 
In our study, TOS levels in patients that underwent LC 
slightly increased during the perioperative period and on 
postoperative day 1, while TAS levels in this group slightly 
decreased; however, the changes in the levels of both TOS 
and TAS were not statistically significant. Of note, PON1 
levels were significantly lower on postoperative day 1 than 
during the preoperative period in the LC group. In addition, 
arylesterase activity was higher during the preoperative 
period than during both the perioperative period and on 
postoperative day 1 in the LC group. 
In contrast, no significant changes in TOS, TAS, 
PON1, and arylesterase activities were observed in Group 
II. Significant changes in well-known oxidative stress 
markers, including TOS and TAS, have been previously 
reported.12,14 In our study, no statistically significant 
changes were observed in the well-known TOS and TAS 
oxidative stress markers in either group. In recent years, 
PON1 and arylesterase have been used as oxidative stress 
markers. In the present study, we observed decreases in 
these new oxidative stress markers. Therefore, we speculate 
that this finding may reflect changes in the splanchnic 
microcirculation caused by pneumoperitoneum during 
LC. In the present study, we also compared perioperative 289
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TAS levels in Groups I and II. The perioperative TAS 
level in Group I was higher than that of Group II (p=0.04). 
Interestingly, the arylesterase level of Group I was also 
higher (p=0.028) than the level in Group II. These results 
support the findings by Bukan et al. 
In conclusion, PON1 and arylesterase levels are useful 
markers for evaluating changes in the oxidative status caused 
by pneumoperitoneum during laparoscopic procedures. In 
addition, high TAS and arylesterase activities occur during 
the perioperative period in patients undergoing LC in 
comparison to patients experiencing open procedures under 
general anesthesia. Therefore, LC patients may show less 
oxidative stress during LC as surgeons become increasingly 
experienced with this technique and as the technique is 
improved. 
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